127 related articles for article (PubMed ID: 4076230)
1. Preparation of 67Ga-labelled human IgG and its Fab fragments using desferoxamine as chelating agent.
Motta-Hennessy C; Eccles SA; Dean C; Coghlan G
Eur J Nucl Med; 1985; 11(6-7):240-5. PubMed ID: 4076230
[TBL] [Abstract][Full Text] [Related]
2. Deferoxamine, a promising bifunctional chelating agent for labeling proteins with gallium: Ga-67 DF-HSA: concise communication.
Yokoyama A; Ohmomo Y; Horiuchi K; Saji H; Tanaka H; Yamamoto K; Ishii Y; Torizuka K
J Nucl Med; 1982 Oct; 23(10):909-14. PubMed ID: 7119886
[TBL] [Abstract][Full Text] [Related]
3. Succinylated polylysine as a possible link between an antibody molecule and deferoxamine.
Slinkin MA; Klibanov AL; Khaw BA; Torchilin VP
Bioconjug Chem; 1990; 1(4):291-5. PubMed ID: 2096922
[TBL] [Abstract][Full Text] [Related]
4. An antibody-desferrioxamine conjugate labelled with 67Ga.
Ward MC; Roberts KR; Babich JW; Bukhari MA; Coghlan G; Westwood JH; McCready VR; Ott RJ
Int J Rad Appl Instrum B; 1986; 13(5):505-7. PubMed ID: 3818312
[TBL] [Abstract][Full Text] [Related]
5. [67Ga]desferrioxamine--HSA: synthesis of chelon protein conjugates using carbodiimide as a coupling agent.
Janoki GA; Harwig JF; Chanachai W; Wolf W
Int J Appl Radiat Isot; 1983 Jun; 34(6):871-7. PubMed ID: 6874113
[TBL] [Abstract][Full Text] [Related]
6. An approach for immunoradiometric assay with metallic radionuclides: gallium-67-deferoxamine-dialdehyde starch-IgG.
Furukawa T; Fujibayashi Y; Fukunaga M; Saga T; Endo K; Yokoyama A
J Nucl Med; 1991 May; 32(5):825-9. PubMed ID: 2022990
[TBL] [Abstract][Full Text] [Related]
7. Preparation of 67Ga-labeled antibodies using deferoxamine as a bifunctional chelate. An improved method.
Koizumi M; Endo K; Kunimatsu M; Sakahara H; Nakashima T; Kawamura Y; Watanabe Y; Ohmomo Y; Arano Y; Yokoyama A
J Immunol Methods; 1987 Nov; 104(1-2):93-102. PubMed ID: 3316401
[TBL] [Abstract][Full Text] [Related]
8. A novel bifunctional metabolizable linker for the conjugation of antibodies with radionuclides.
Arano Y; Matsushima H; Tagawa M; Koizumi M; Endo K; Konishi J; Yokoyama A
Bioconjug Chem; 1991; 2(2):71-6. PubMed ID: 1868115
[TBL] [Abstract][Full Text] [Related]
9. 67Ga-labeled antibodies for immunoscintigraphy and evaluation of tumor targeting of drug-antibody conjugates in mice.
Koizumi M; Endo K; Kunimatsu M; Sakahara H; Nakashima T; Kawamura Y; Watanabe Y; Saga T; Konishi J; Yamamuro T
Cancer Res; 1988 Mar; 48(5):1189-94. PubMed ID: 3422590
[TBL] [Abstract][Full Text] [Related]
10. Elimination of free radionuclide by a chelating agent improves tumor-to-nontumor ratios following radioimmunotargeting with antibody labeled with 67Ga.
Ryser JE; Rose K; Jones R; Pelegrin A; Donath A; Egeli R; Smith A; Offord RE
Nucl Med Biol; 1998 Apr; 25(3):261-5. PubMed ID: 9620632
[TBL] [Abstract][Full Text] [Related]
11. Gallium-labeled deferoxamine-galactosyl-neoglycoalbumin: a radiopharmaceutical for regional measurement of hepatic receptor biochemistry.
Vera DR
J Nucl Med; 1992 Jun; 33(6):1160-6. PubMed ID: 1597732
[TBL] [Abstract][Full Text] [Related]
12. Labeling of monoclonal antibodies with a 67Ga-phenolic aminocarboxylic acid chelate. Part I. Chemistry and labeling technique.
Schuhmacher J; Matys R; Hauser H; Maier-Borst W; Matzku S
Eur J Nucl Med; 1986; 12(8):397-404. PubMed ID: 3792374
[TBL] [Abstract][Full Text] [Related]
13. Optimal conditions for the preparation of Fab and F(ab')2 fragments from monoclonal IgG of different rat IgG subclasses.
Rousseaux J; Rousseaux-Prévost R; Bazin H
J Immunol Methods; 1983 Nov; 64(1-2):141-6. PubMed ID: 6644029
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, purification, and tumor cell uptake of 67Ga-deferoxamine--folate, a potential radiopharmaceutical for tumor imaging.
Wang S; Lee RJ; Mathias CJ; Green MA; Low PS
Bioconjug Chem; 1996; 7(1):56-62. PubMed ID: 8741991
[TBL] [Abstract][Full Text] [Related]
15. The effect of chelating agents on the distribution of monoclonal antibodies in mice.
Ward MC; Roberts KR; Westwood JH; Coombes RC; McCready VR
J Nucl Med; 1986 Nov; 27(11):1746-50. PubMed ID: 3464701
[TBL] [Abstract][Full Text] [Related]
16. A comparison of cleavable and noncleavable hydrazinopyridine linkers for the 99mTc labeling of Fab' monoclonal antibody fragments.
Bridger GJ; Abrams MJ; Padmanabhan S; Gaul F; Larsen S; Henson GW; Schwartz DA; Longley CB; Burton CA; Ultee ME
Bioconjug Chem; 1996; 7(2):255-64. PubMed ID: 8983348
[TBL] [Abstract][Full Text] [Related]
17. In vivo kinetics and thrombus accumulation of 67Ga-labeled urokinase.
Ohmomo Y; Yokoyama A; Yamauchi Y; Horiuchi K; Saji H; Tanaka C; Torizuka K
Int J Nucl Med Biol; 1985; 12(1):47-52. PubMed ID: 4008166
[TBL] [Abstract][Full Text] [Related]
18. Structural modifications of monoclonal antibodies following direct versus indirect labelling with 99Tcm: does fragmentation really occur?
Behr T; Becker W; Hannappel E; Wolf F
Nucl Med Commun; 1994 Nov; 15(11):865-70. PubMed ID: 7870392
[TBL] [Abstract][Full Text] [Related]
19. Labeling of sarcoma associated monoclonal antibody with 111In, 67Ga and 125I.
Lavie E; Boazi M; Weininger J; Bitton M; Yosilevski G; Front D; Hirshaut Y; Robinson E; Bartal AH
Radiother Oncol; 1987 Feb; 8(2):129-35. PubMed ID: 3562892
[TBL] [Abstract][Full Text] [Related]
20. The binding parameters of radiolabelled monoclonal F (ab')2 and Fab' fragments relative to immunoglobulin G in reactions with surface-bound antigens.
Fjeld JG; Michaelsen TE; Nustad K
Eur J Nucl Med; 1992; 19(6):402-8. PubMed ID: 1618231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
